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Background: Cost effectiveness analysis (CEA) is a useful tool for allocation of constrained resources, yet CEA
methodologies are rarely taught or implemented in developing nations. We aimed to assess exposure to, and
interest in CEA, and identify barriers to implementation in Uganda.
Methods: A cross-sectional survey was carried out in Uganda using a newly developed self-administered
questionnaire (via online and paper based approaches), targeting the main health care actors as identified by a
previous study.
Results: Overall, there was a 68% response rate, with a 92% (69/75) response rate among the paper-based
respondents compared to a 40% (26/65) rate with the online respondents. Seventy eight percent (74/95) of the
respondents had no exposure to CEA. None of those with a master of medicine degree had any CEA exposure, and
80% of technical officers, who are directly involved in policy formulation, had no CEA exposure. Barriers to CEA
identified by more than 50% of the participants were: lack of information technology (IT) infrastructure (hardware
and software); lack of local experts in the field of CEA; lack of or limited local data; limited CEA training in schools;
equity or ethical issues; and lack of training grants incorporating CEA. 93% reported a lot of interest in learning to
conduct CEA, and over 95% felt CEA was important for clinical decision making and policy formulation.
Conclusions: Among health care actors in Uganda, there is very limited exposure to, but substantial interest in
conducting CEA and including it in clinical decision making and health care policy formation. Capacity to
undertake CEA needs to be built through incorporation into medical training and use of regional approaches.
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In the past 20 years, cost-effectiveness analysis (CEA)
has become increasingly popular as a means of assessing
the value of health care treatments. CEA endeavors to
guide decision making such as to compare the health
benefits of competing treatments within the context of
cost. While these methods have been refined and gained
traction in developed nations, there has been little use of
CEA in developing nations [1]. Countries with scarce
health care resources would logically stand to gain most
from these methods to optimize allocation of those
scarce resources. In Sub-Saharan Africa (SSA), adverse
factors ranging from civil wars and extreme poverty to
high rates of infectious disease strain health care budgets* Correspondence: axk95@case.edu
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unless otherwise stated.and delivery systems, making optimal allocation of
health care especially important. Taken in the context of
an expected doubling of the population in the next
25 years [2], it becomes even more urgent that CEA be
more widely conducted and used to inform policy and
practice. Accordingly, the World Health Organization
(WHO) recommends incorporation of CEA in policy
formulation and practice [3]. Despite all this, CEA publi-
cations in developing countries are few [1], and some have
employed inconsistent and often flawed methodology [4].
Additional potential barriers to the conduct and impact
of CEA in developing nations include lack of trained local
personnel, lack of local data, and poor infrastructure [5].
Other hypothesized barriers include a shortage of CEA
experts and lack of familiarity with CEA among policy
makers and opinion leaders.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0) which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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oping countries continues to show that CEA is perceived
as important for decision making. A study done among
Ugandan health workers and policy makers showed that
about 90% of all respondents recognized both disease
severity and cost effectiveness as very important in health
care decision making [6]. However, we have not come
across studies which have attempted to document key ac-
tors’ perspectives in regard to the barriers which attenuate
the influence of CEA in policy formulation and practice in
Sub-Saharan Africa.
In a commentary on the role of pharmacoeconomics
in developing countries that was recently published in
PharmacoEconomics, Babar and Scahill [7] argue that
“there is a need for a model that could aid in determining
the perceived need and benefits of using pharmacoeco-
nomics in formulary development in a given developing
country”. By providing primary research on the exposure,
interest and barriers to CEA in the context of a developing
Sub-Saharan African nation, our study attempts to make a
contribution to this effect.
This study aims to identify barriers to the conduct
of CEA and its impact on policy and practice in a Sub-
Saharan African country, Uganda. It also assesses the
interest in and exposure to CEA methods, as well as the
frequency of use of CEA in actual health care policy and
practice.
Methods
We carried out a cross sectional survey of the different
health care delivery actors in Uganda. Self-administered
questionnaires were used. In order to increase the response
rate, we used both paper-based and online questionnaires.
After two reminders (chosen arbitrarily) were given follow-
ing no response on the paper version, we would send the
online version. This approach was not effective and was
applied to only six participants. We eventually opted to
invite all those who had not completed the paper version
to complete an online questionnaire. The online ques-
tionnaires were designed and administered using REDCap
Survey Software (version 1.3.10; Vanderbilt University,
Tennessee, USA).
Questionnaires were sent out to health care workers;
technical officers at the Ministry of Health (these are
directly involved in policy formulation), post-graduate
students training in health- related fields, and professors
in the medical schools.
Health care workers and students were drawn from
the two main teaching hospitals namely: Mulago teaching
hospital for Makerere University and Mbarara University
teaching hospital for Mbarara University of Science
and Technology. The two hospitals were selected be-
cause they are the two main teaching hospitals in
Uganda; it is the students trained in these hospitalsthat end up being the main decision makers in
health care.
The study participants were selected as follows: For
the Ministry of Health Officials, we contacted a senior
officer and after we described the study to him, he
advised us to send questionnaires to specific individuals
from 3 departments that are involved in economic evalua-
tions, namely Planning − 5 respondents; Clinical Services-
5 respondents; and Community Health- 5 respondents.
For the students in the two medical schools, we obtained
a list of names of postgraduate students from the program
administrators and randomly selected those to whom the
questionnaires were sent. We obtained a similar list
for health care workers at the level of medical officer
and above and randomly selected respondents. We
also sent questionnaires to directors or deputy directors of
Non-governmental organizations involved in health care
delivery. All participants were fluent in English, so it was
not necessary to provide translations.
Data was collected between July and October 2010.
Bi-weekly e-mail reminders were sent to participants.
The study received IRB approval from the Case Western
Reserve University Institutional Review Board (IRB) and
the Makerere University Faculty of Medicine Scientific and
Ethics committee, with final approval from the Ugandan
National Council of Science and Technology. This study
was conducted under standard ethical practices.
Statistical analysis
Data were entered online using REDCap Survey, and
analyzed using SAS (version 9.2; SAS Institute,Cary
North Carolina,USA). We carried out descriptive analyses
looking at the demographic characteristics of respondents
such as sex, education and work place.
Exposure to CEA was treated as a binary variable i.e.
some exposure (for those who had some or a lot of expos-
ure during their training, current or past) and no exposure
(for those who had no exposure). Some exposure as used
in this paper refers to whether someone was exposed
to CEA through their current or past training and/or
through any other setting such as short term trainings,
conferences/workshops, grand rounds, online material
and journal clubs.
A lot of exposure refers to someone who had class-
room training in CEA and he/she is currently actively
carrying out or involved in CEA research. No exposure
means someone who did not have any exposure to CEA
prior to this study.
All questions involving a five-point scale of strongly
agree, agree, neutral, disagree and strongly disagree, were
re-coded as agree (strongly agree and agree) and disagree
(neutral, disagree and strongly disagree). Neutral was in-
cluded in the disagree category to bias results against the
null hypothesis.








Ministry of Health 15 (15.7)





Bachelor of medicine/MD 59 (62.1)






Postgraduate training/MMED 17 (18.9)
MS/MPH 16 (16.8)
PhD in a health related field (e.g. epidemiology




*‘Other’ included master of business administration (MBA) and masters in human
resource management.
**The other category included individuals who were pursuing a master’s degree
in business administration and master’s degree in management.
(N =95).
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or learning to conduct CEA were coded as: a lot of inter-
est (a lot of interest) and not a lot of interest (little, some
or no interest).
Questions involving the frequency of use of CEA were
coded as: always, sometimes, and rarely or never.
In order to test associations, we did a chi-square good-
ness of fit test to test whether the observed proportions
for ‘agree’ or ‘disagree’ were different when a given ques-
tion concerned policy versus when the same question
concerned clinical practice.
In addition, we did chi-square tests looking at the
association between interest in conducting or learning to
conduct CEA versus exposure to CEA. We also asked
participants about potential barriers to CEA and their
solutions.
Results
A total of 134 questionnaires were sent out. Of these 75
(57.2%) were paper-based and 65 (46.4%) were online. Six
of the 65 online ones were from those who received the
paper-based version and never responded. The remaining
59 were all sent directly online. Of the 75 paper- based
ones, 69 (92.3%) were returned, but only 26 (40%) of the
65 online participants responded. Results are derived from
a total of 95 (68%) returned questionnaires.
Majority of the respondents were employees of tertiary/
referral hospitals and universities. These accounted for
34% and 28% respectively. The mean age of respondents
was 36 years and males represented 61% of all respon-
dents (Table 1).
Seventy eight percent (74/95) of the respondents had
no exposure; the remaining 22% (21/95) only had some
exposure to cost effectiveness analysis. Nobody had a lot
of exposure. Among those with a bachelor of medicine
degree, only 19% (11/59) had some level of exposure to
cost effectiveness analysis compared to 81% (48/59) who
had no exposure to CEA. None (0/8) of those with master
of medicine degree (MMED) had exposure to CEA and
only 25% (3/12) of those with MS or MPH had some
exposure to CEA (Table 2).
Looking at exposure to CEA by work place also showed
interesting findings. Among those working for the mi-
nistry of health, 12/15 (80%) had no CEA exposure. For
tertiary/referral hospitals workers and university faculty,
only 11/32 (34%) and 6/27 (22%) respectively, had some
exposure to CEA. None (0/20) of those working for a
non-governmental organization had any exposure to CEA.
Barriers to CEA identified by more than 50% of the
participants were: lack of local experts in the field of
CEA; lack of or limited local data; limited CEA training
in schools; equity or ethical issues; lack of training
grants incorporating CEA and lack of IT infrastruc-
ture. This meant the actual lack of or much limitedsupply of hardware such as computers and lack of or
limited licenses to software packages such as TreeAge,
which are used in economic evaluations such as CEA.
There was no statistical difference as to whether these
were more of barriers in relation to policy or clinical
practice. Participants also overwhelmingly agreed that
improving these barriers will go a long way in increasing
the use of CEA in policy and clinical practice (Table 3).
Majority of the respondents overwhelmingly agreed
that CEA should play an important role in policy and
clinical practice. Again there was no statistical difference
as to whether perception of the importance of CEA was
in relation to policy or clinical practice (Table 4).
Among those who had no exposure to CEA, 43% (32/74)
had a lot of interest in conducting CEA compared to 57%
(42/74) who did not have a lot of interest in conducting
CEA. Among those who had some exposure to CEA, 30%
(6/20) had a lot of interest in conducting CEA compared
Table 2 Respondents’ exposure to cost effectiveness
analysis by their current level of training and work-place
(N = 94)







48 (81.4) 11 (18.7)
Post graduate (MMED) 8 (100.0) 0 (0.0)
MS/MPH 9 (75.0) 3 (25.0)
PhD 2 (100.0) 0 (0.0)
*Other 7 (53.9) 6 (46.2)
Work-place
Ministry of Health 12 (80.0) 3 (20.0)
Tertiary/referral hospital 21 (65.6) 11 (34.4)
University 21 (77.8) 6 (22.2)
Non Governmental Organization 20 (100.0) 0 (0.0)
Current training
Postgraduate training/MMED 14 (82.4) 3 (17.6)
MS/MPH 12 (75.0) 4 (25.0)
PhD in a health related
field (e.g. epidemiology
or Health Services Research)
17 (73.9) 6 (26.1)
*Other 31 (81.6) 7 (18.4)
Missing 0 (0.0) 1 (100.0)
*‘Other’ included master of business administration (MBA) and masters in human
resource management.









Lack of experts in the field of cost
effectiveness analysis
81 (87.1) 76 (81.7)
N.S
Lack of or limited local data 85 (91.4) 82 (88.2)
N.S
Limited CEA training in schools 89 (95.7) 86 (92.5)
N.S
Fairness and ethical concerns 47 (50.5) 49 (54.1)
N.S
Lack of training grants incorporating CEA 61 (65.6) 63 (67.7)
N.S
N.S: Chi-square goodness of fit test showed that the observed proportions of agree
concerned policy or clinical practice.
N/A: Not applicable.
**Is based on N =94, all the other proportions in the table are based on N =93. The
responding to certain questions.
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ducting CEA.
The picture was slightly different when we looked at
CEA exposure versus interest in learning to conduct
CEA. Although not statistically significant, respondents
who had no exposure to CEA compared to those who
had some exposure were slightly less likely to be inter-
ested in learning to conduct CEA, 58% (43/74) vs. 65%
(13/20), p = 0.08.
In general, most of the respondents frequency of using
CEA in making clinical or policy decisions ranged between
sometimes to rarely or never (Table 5).
Discussion
In the resource-constrained countries of Sub-Saharan
Africa (SSA), where policy and decision makers are
frequently faced with tough decisions regarding resource
allocation, cost effectiveness analysis (CEA) can be a
useful tool for optimal allocation of scarce resources.
This study shows that the health care actors in Uganda
perceive cost effectiveness analysis as an important part
of the decision making process.
This study identified the lack of exposure to CEA and
the lack of trained individuals to conduct CEA as the
two main barriers to CEA playing a substantial role in
health care decision making in Uganda. Just like in
Thailand and other developing countries [8], the majority
of the health policy decision makers in Uganda are me-
dically trained. Systemic introduction of CEA methods
into medical training is necessary, and also requires the
creation of training grants for CEA.lation Solving enhances use of CEA
in clinical practice n (%)
Solving enhances use of CEA
in policy formulation n (%)
75 (80.7) 79 (85)
N.S
89 (95.7) 89 (95.7)
N.S
88 (94.6) 90 (96.8)
N.S




73 (78.5) 74 (79.6)
N.S
ing to a given barrier were not statistically different whether the barrier
se are less than 95 because of missing data resulting from participants not
Table 4 Respondents’ perceived importance of cost







CEA should play an important role 92 (96.8) 91 (95.8)
N.S
Your colleagues think that CEA
should play an important role
69 (72.6) 74** (78.7)
N.S
N.S: Chi-square goodness of fit test showed that the observed proportions of
agreeing to the importance of CEA were not statistically different whether the
importance was in relation to policy or clinical practice.
**Is based on N = 94 because of a missing data point, all the other proportions in
the table are based on N = 95.
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nations have used to increase the knowledge and skills
to carry out CEA should be applied to developing coun-
tries. Noteworthy is the fact that the approaches adopted
should be modified in ways which make them appro-
priate in the local context. This will enhance the impact
of CEA in the decision making process. A review by
Alan Stewart, Jordana K. Schmier, & Bryan R. Luce,
1999 [9] has documented some of these strategies.
Jauregui et al., 2011, describes the Pan-American Health
Organization (PAHO) ProVac Initiative’s approach. This
initiative was in response to the request by country man-
agers of vaccine programs for additional technical support
in the use of cost-effectiveness analysis and other forms
of economic evaluations of competing interventions. Its
implementation inter-alia resulted into new models for
cost-effectiveness analysis; innovative data collection
tools; CEA trainings at regional levels; technical support
to individual nations that ask for it and development of
web-based based technical support systems [10]. These
lessons can be applied to SSA.
In addition, the WHO-CHOICE(CHOosing Interven-
tions that are Cost-Effective) project provides key informa-
tion needed to standardize CEA methods, and also takes a
sectoral perspective where the costs and effectiveness of a
wide range of interventions are compared in order toTable 5 Respondents’ frequency of use of cost effectiveness a
How often have you been involved in doing CEA?**
How often have you (personally) had to interpret CEA during your practice o
How frequently do you read an article (s) that compares the cost effectivene
more interventions?
In the past 12 months, have you considered cost effectiveness analysis result
decisions during your clinical practice?
In the past 12 months, have you considered cost effectiveness analysis result
formulating any policies?
How often do you involve CEA in discussing policy or practice at your schoo
How often have you been involved in reviewing CEA?
**Proportions based on N =95, due to one missing data value all the other proportiidentify those that maximize health from a given set of
resources. The WHO-CHOICE project also assembles
regional databases on the costs, and impact on population
health. It also provides cost-effectiveness of key health
interventions, as well as a contextualization tool, enabling
adaption of regional results to the country level [3].
In this study, less than one in four had any exposure
to CEA, including the subset of Ministry of Health em-
ployees. Furthermore, more than 80% identified lack
of local experts as a barrier to the use of CEA. Simi-
lar findings have been observed among policy makers
in Thailand, where only 29% were able to define the con-
cept of economic evaluations [8]. Following these findings,
interventions such as capacity building using various ap-
proaches like short-term trainings, workshops, and confer-
ences about CEA methodologies and approaches have
been widely implemented in Thailand [5]. With necessary
modifications to make them locally appropriate, these
should be adopted in Uganda and other developing or
poorest countries.
This study identified other barriers similar to those
identified by a range of policymakers in a Thailand study
[5]. Among these is the lack of infrastructure and physical
tools like computers and associated software.
In addition, there is limited local data and policy makers
are routinely using clinical data from other countries.
In Thailand, the Health Intervention and Technology
Assessment Program has adopted certain principles, such
as technical excellence and policy relevance to enhance
the utilization of its research findings by policy makers
and other stakeholders [5].
There is a need for establishing cost effectiveness
analysis institutes in SSA to guide research involving CEA
and also carry out capacity building activities. While some
developing nations like Thailand have been able to do this
on their own, for the extremely impoverished countries
of Sub-Saharan Africa, it may be necessary to establish a
regional body. This may start by establishing a think







3 (3.2) 24 (25.3) 68 (71.6)
r decision making? 6 (6.4) 41 (43.6) 47 (50.0)
ss of two or 2 (2.1) 50 (53.2) 42 (44.7)
s when making 10 (10.6) 39 (41.5) 45 (47.9)
s when 10 (10.7) 32 (34) 52 (53.3)
l or place of work? 8 (8.5) 50 (53.2) 36 (38.3)
2 (2.1) 26 (27.7) 66 (70.2)
ons in the table are based on N = 94.
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nomic policy research center in Uganda, the Kenya
Medical Research Institute, and the Botswana institute
of social policy to guide capacity building for CEA in
SSA. This approach should be part of an overall strategy
and can help define a better, sustainable process for in-
creasing awareness and capacity to conduct the analysis.
Furthermore, fairness and ethical concerns were also
cited as significant barriers to CEA. Societal values such
as equity may sometimes conflict with the conclusions
of CEA evaluations. For example, providing universal
access to second-line antiretroviral therapy (ART) for
treating HIV/AIDS patients may not prove to be as cost-
effective, but may be preferable to society [11].
On the other hand, the fact stands that affordability of
an otherwise cost effective intervention can be a barrier to
wide spread use of knowledge gained from CEA. The add-
itional cost of the program (affordability) when fully im-
plemented may be prohibitive for a given country [12,13]
despite a favorable ICER per outcome for one person.
A high proportion of those who had no CEA exposure
had a lot of interest in learning to conduct it, yet only
35% of those who had some exposure had a lot of inter-
est in learning to conduct CEA. This may be because
people who have had some exposure to CEA may better
realize how complex CEA can be, and may prefer not
to make the investment of time to learn to do it
themselves. They still found it important to do CEA.
Indeed, developing capacity to conduct CEAs will likely
require the teaching of these methods in quantitative
health-related disciplines such as epidemiology and
biostatistics and might be augmented by the Ministry
of Health requiring staff be knowledgeable and skilled
in CEA.
Also noteworthy was the finding that none of the
twenty individuals employed by NGOs reported any
exposure to CEA. This may be because many NGOs have
specific well-funded missions, and are not conducting
CEA and formulating policy.
It is worth noting that although CEA may be essential
for guiding resource allocation, its use might be limited
in countries like Uganda, where resource allocation for
health care is governed by a number of stakeholders
including government and development partners such as
Global fund, that may be interested in funding specific
programs, e.g., Malaria, HIV/AIDS, medicines and diag-
nostics etc. [14].
In such settings, the lack of a single unitary agency e.
g., the ministry of health that governs resource allocation
limits the use of CEA tools to inform resource allocation
at a sector level. This creates inefficiencies. However,
within a sector program e.g., HIV/AIDS Anti-retro-viral
drugs, there might be circumstances where CEA tools
might be applicable.The biggest limitation of this study is the small sample
size, with limited power to detect significant differences
between subgroups. However, the sample size was ade-
quate to support the exploratory aims of our study which
will guide future studies and interventions. Having men-
tioned that however, participants in this study belonged to
categories that were identified as the main health care
actors in Uganda [6] and elsewhere [15], therefore the in-
formation they provide is assumed to be both relevant and
reliable. As with any self-administered questionnaire,
we also cannot rule out the possibility of poor question
interpretation [16]. Nevertheless, systematic analysis of
our questionnaire results did not identify any specific
questions that appeared to be interpreted illogically.
Conclusions
This study demonstrates that despite substantial interest,
significant barriers have to be dealt with if cost effective-
ness analysis is to have a significant impact on policy and
practice in Sub-Saharan Africa. More locally generated data
is needed, as is improved infrastructure, and increased
local expertise. The study also highlights the unfortunate
reality that despite acknowledgement of the importance of
CEA and interest in learning to conduct it, very few health
care actors in Uganda have sufficient exposure to CEA for
these methods to impact policy. If cost effectiveness ana-
lysis is to take root in Sub-Saharan African countries like
Uganda, there must be concerted effort to increase expos-
ure to CEA at all levels of training.
Since political pressure also plays a role in decision
making [8], there is a need for effective dialogue with all
the involved stakeholders, particularly political represen-
tatives so that they understand the appropriate role for
CEA in policy making.
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